Cleared Special

K990494 - MODIFICATION OF NOGA

K990494 is an FDA 510(k) clearance for MODIFICATION OF NOGA, manufactured by Biosense, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 198-day FDA review.

K990494 · Biosense, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1999
Decision
198d
Days
Class 2
Risk

K990494 is an FDA 510(k) clearance for the MODIFICATION OF NOGA. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Biosense, Inc. (Diamond Bar, US). The FDA issued a Cleared decision on September 3, 1999 after a review of 198 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Biosense, Inc. devices

FDA 510(k) Submission Details - K990494

510(k) Number K990494 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 1999
Decision Date September 03, 1999
Days to Decision 198 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d slower than avg
Panel avg: 125d · This submission: 198d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 359
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K990494.
SYNEFLASH & SYNEVIEW
K990727 · Ela Medical, Inc. · Nov 1999
IMPRESARIO
K993620 · Del Mar Medical Systems, LLC · Nov 1999
CARTO EP NAVIGATION SYSTEM
K992968 · Biosense Webster, Inc. · Sep 1999
BIOSENSOR HOLTER MONITOR SYSTEM SOFTWARE, MODEL 1005
K990956 · Biosensor Corp. · Jun 1999
CARDIAC DIAGNOSTIC SYSTEM MODEL CH 2000
K983102 · Cambridge Heart, Inc. · Apr 1999
MT-200
K973751 · Schiller America, Inc. · Aug 1998